Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 21.0B | 21.5B | 19.5B | 19.3B |
Cost of revenue | 9.7B | 9.7B | 8.7B | 8.6B |
Gross profit | 11.3B | 11.8B | 10.8B | 10.7B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 7.4B | 7.7B | 6.8B | 6.9B |
Operating income | 1.7B | 1.9B | 2.0B | 2.0B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 1.2B | 1.3B | 1.4B | 1.3B |
Other income expense | — | — | — | — |
Pretax income | 695.2M | 733.0M | 869.9M | 796.3M |
Tax provision | 194.0M | 236.7M | 154.7M | 188.3M |
Net income | 493.3M | 432.4M | 665.3M | 580.2M |
Basic EPS | — | 0.7 | 1.0 | 0.9 |
Diluted EPS | — | 0.7 | 1.0 | 0.9 |
Basic average shares | — | 660.2M | 660.3M | 656.5M |
Diluted average shares | — | 660.2M | 660.3M | 656.5M |
EBITDA | 4.0B | 4.2B | 4.3B | 4.0B |
Net income from continuing op. | — | — | — | — |
Minority interests | -13.3M | -3.3M | -24.8M | -22.2M |
Preferred stock dividends | 0 | 0 | 0 | 0 |